ALS related metabolic pathway discovered by Sheffield scientists using Biolog technology Discovery could open doorway to new treatment Sheffield, UK and Hayward, CA, USA –February 13, 2019–Researchers at the University of Sheffield have identified a new pathway that is disrupted in amyotrophic lateral sclerosis (ALS), a debilitating and ultimately lethal motor neuron disease (MND). The...Read More
About Us
Biolog is a world leader in cell-based phenotypic testing technologies and assays. We have focused our efforts on developing technologies and products to test properties of cells (phenotypes) very simply and efficiently.